IDO1 and neoplasm: In tumor-draining lymph nodes, IDO1 expression of DCs is induced, and IDO1-expressing DCs suppress effector T cell proliferation and activate regulatory T cells because of tryptophan deprivation, downstream kynurenine, and other metabolites [17,18,19].